SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (NASDAQ: SERA ), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will report second quarter fiscal year 2024 financial results on Wednesday, August 7, 2024 , after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.
m. Eastern Time . A press release outlining the financial results and highlights will be publicly distributed before the call.
Conference Call Details : US domestic callers: (800) 836-8184 International callers: (646) 357-8785 Webcast Registration Link : https://app.webinar.net/9o5EWBrWj02 Live audio of the webcast will be available online from the Investors page of the Company's website at www.
seraprognostics.com . The webcast will be archived on the Investors page and will be available for one year.
About Sera Prognostics, Inc. Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to provide early, pivotal pregnancy information to improve the health of mothers and newborns, resulting in reductions in the costs of healthcare delivery.
Sera has a robust pipeline of innovative diagnostic tests focused on the early prediction of preterm birth.